Impact of Midregional N-Terminal Pro-Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study.

Marc Badoz,Guillaume Serzian,Baptiste Favoulet,Jean-Marc Sellal,Christian de Chillou,Nefissa Hammache,Gabriel Laurent,Alexandre Mebazaa,Fiona Ecarnot,Karine Bardonnet,Marie-France Seronde,Francois Schiele,Nicolas Meneveau

Impact of Midregional N-Terminal Pro-Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study.

2021

Marc Badoz
Guillaume Serzian
Baptiste Favoulet
Jean-Marc Sellal
Christian de Chillou
Nefissa Hammache
Gabriel Laurent
Alexandre Mebazaa
Fiona Ecarnot
Karine Bardonnet
Marie-France Seronde
Francois Schiele
Nicolas Meneveau

Background We assessed the impact of preprocedural plasma levels of MRproANP (midregional N‐terminal pro–atrial natriuretic peptide) and sST2 (soluble suppression of tumorigenicity 2) on recurrence...

Keywords:

Atrial fibrillation
Natriuretic peptide
Biorhythm
Internal medicine
Heart Rhythm
pro atrial natriuretic peptide
in patient
Medicine
Cardiology
plasma levels
Catheter ablation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations